- Home
- NATH vs ENGN Comparison
NATH vs ENGN Comparison
Compare NATH & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NATH
- ENGN
- Stock Information
- Founded
- NATH 1916
- ENGN 1999
- Country
- NATH United States
- ENGN Canada
- Employees
- NATH N/A
- ENGN N/A
- Industry
- NATH Restaurants
- ENGN
- Sector
- NATH Consumer Discretionary
- ENGN
- Exchange
- NATH Nasdaq
- ENGN Nasdaq
- Market Cap
- NATH 385.4M
- ENGN 297.7M
- IPO Year
- NATH N/A
- ENGN N/A
- Fundamental
- Price
- NATH $93.95
- ENGN $4.90
- Analyst Decision
- NATH
- ENGN Buy
- Analyst Count
- NATH 0
- ENGN 9
- Target Price
- NATH N/A
- ENGN $25.22
- AVG Volume (30 Days)
- NATH 13.8K
- ENGN 28.7K
- Earning Date
- NATH 02-06-2025
- ENGN 03-10-2025
- Dividend Yield
- NATH 2.12%
- ENGN N/A
- EPS Growth
- NATH 24.88
- ENGN N/A
- EPS
- NATH 5.80
- ENGN N/A
- Revenue
- NATH $146,386,000.00
- ENGN N/A
- Revenue This Year
- NATH N/A
- ENGN N/A
- Revenue Next Year
- NATH N/A
- ENGN N/A
- P/E Ratio
- NATH $16.24
- ENGN N/A
- Revenue Growth
- NATH 6.83
- ENGN N/A
- 52 Week Low
- NATH $64.02
- ENGN $4.42
- 52 Week High
- NATH $104.96
- ENGN $18.40
- Technical
- Relative Strength Index (RSI)
- NATH 49.16
- ENGN 34.47
- Support Level
- NATH $91.57
- ENGN $4.90
- Resistance Level
- NATH $96.39
- ENGN $5.50
- Average True Range (ATR)
- NATH 2.11
- ENGN 0.55
- MACD
- NATH -0.74
- ENGN 0.00
- Stochastic Oscillator
- NATH 30.76
- ENGN 21.17
About NATH Nathan's Famous Inc.
Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.